Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Jihlava

45 clinical trials in Jihlava, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Jihlava at a glance
45
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

45 trials in Jihlava

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Atrial fibrillation

Not yet recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Parkinson's disease

Not yet recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ioflupane (123I)
  • Sponsor:Biohaven Therapeutics Ltd.
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Jihlava

What the registry says about research in the country

01 Neurological Studies

Extensive research focusing on multiple sclerosis treatments, including studies of novel therapies like frexalimab and comparative analyses of established medications. Clinical trials are evaluating both relapsing and progressive forms of MS, with emphasis on long-term efficacy and safety.

  • Multiple Sclerosis (Relapsing and Progressive)
  • Treatment Effectiveness Studies
  • Long-term Safety Monitoring

Several trials are investigating new delivery methods and formulations to improve patient outcomes.

02 Cardiovascular Research

Innovative studies targeting cardiovascular diseases, including trials for heart failure, myocardial infarction, and stroke prevention. Research includes evaluation of new compounds for reducing cardiovascular events and improving patient outcomes.

  • Acute Myocardial Infarction
  • Heart Failure Management
  • Stroke Prevention

Focus on both preventive measures and acute treatment strategies for cardiovascular conditions.

03 Respiratory Medicine

Clinical trials examining new treatments for severe asthma and related respiratory conditions. Studies are evaluating novel medications and delivery systems to improve symptom control and reduce exacerbations.

  • Severe Asthma Management
  • Inhaler Technology
  • Exacerbation Prevention

Research emphasizes both immediate symptom relief and long-term disease control.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.